Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV

Details for Australian Patent Application No. 2009331530 (hide)

Owner Ortho-McNeil-Janssen Pharmaceuticals, Inc

Inventors Horvath, Andras; Ormerod, Dominic John; Depre, Dominique Paul Michel; Cerpentier, Veronique

Agent Shelston IP

Pub. Number AU-A-2009331530

PCT Pub. Number WO2010/072742

Priority 08172691.1 23.12.08 EP

Filing date 22 December 2009

Wipo publication date 1 July 2010

International Classifications

C07D 311/06 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 453/04 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

Event Publications

23 June 2011 PCT application entered the National Phase

  PCT publication WO2010/072742 Priority application(s): WO2010/072742

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009331531-Immunostimulating saponins for use in in situ tumor-destruction therapy

2009331529-Targeted binding agents directed to alpha5beta1 and uses therefor